Diethylstilbestrol Dilaurate

Diethylstilbestrol Dilaurate (DES Dilaurate) is a synthetic, nonsteroidal estrogen that was historically used in various medical applications, most notably in hormone therapy. It is a derivative of diethylstilbestrol (DES), a drug that has been the subject of significant controversy due to its association with various health issues when used by pregnant women. DES Dilaurate, as a specific formulation, has unique properties and applications that distinguish it from its parent compound, DES.

Overview

Diethylstilbestrol Dilaurate is a fat-soluble ester of diethylstilbestrol, which allows it to have a longer duration of action compared to the parent compound. This characteristic made it particularly useful in situations where a prolonged estrogenic effect was desired. It was used in veterinary medicine and in some cases in human medicine, although its use has significantly declined due to safety concerns associated with DES.

History

The history of Diethylstilbestrol Dilaurate is closely tied to that of diethylstilbestrol. DES was first synthesized in 1938 and was widely used for a variety of medical conditions, including as a hormone replacement therapy and for the prevention of miscarriages. However, in the early 1970s, it was discovered that exposure to DES during pregnancy was linked to a rare form of vaginal cancer in daughters of women who had taken the drug, as well as other reproductive issues. This led to a reevaluation of the safety of DES and its derivatives, including DES Dilaurate.

Pharmacology

The pharmacological action of Diethylstilbestrol Dilaurate is primarily estrogenic. By mimicking the action of estrogen, it can influence various physiological processes. Its fat-soluble nature means that it is absorbed and metabolized differently than water-soluble forms of estrogen, leading to a prolonged effect in the body.

Uses

Historically, Diethylstilbestrol Dilaurate was used in hormone therapy, particularly in situations where a long-lasting estrogen effect was beneficial. This included certain menopausal symptoms, prostate cancer, and in veterinary medicine to promote growth and feed efficiency in livestock. However, its use has been largely discontinued due to safety concerns.

Safety and Side Effects

The safety profile of Diethylstilbestrol Dilaurate is similar to that of DES, with significant risks associated with its use. These include an increased risk of certain cancers, reproductive issues, and cardiovascular problems. Due to these risks, the use of DES Dilaurate is highly restricted, and it is no longer commonly prescribed.

Current Status

Today, the use of Diethylstilbestrol Dilaurate is virtually nonexistent in human medicine, largely due to the adverse effects associated with DES. Its use in veterinary medicine has also declined sharply. The legacy of DES and its derivatives, including DES Dilaurate, remains a cautionary tale in the history of medicine, highlighting the importance of long-term safety studies for pharmaceuticals.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian